Episode 30: Early Head and Neck Cancer

Thirty episodes ago, two young doctors took their first steps into the podcasting sphere, stumbling as two newborn foals birthed into a paddock full of fully functioning stallions, presenting a niche. Since then, they have blossomed before your ears into two vaguely competent podcasters, still finding their feet but growing in confidence, if not skill. Our continued existence, we owe entirely to you, our wonderful audience. You are why we continue to front up to our microphones every week, often wearing our pyjamas, but that's beside the point. What we're trying to say is thank you from the bottom of our hearts.

To express our gratitude, we have prepared a niche episode for our niche podcast, examining the treatment of early head and neck cancer. This topic can befuddle even the most experienced oncologists with its confusing, contradictory cornucopia of confirmatory cancer clues. So listen on as Michael and Josh try to clear a path through the dense jungle, like Doctor Livingstone BEFORE he went missing. Have I met my metaphor quota yet?

Links to studies discussed in this episode (subscription may be required):

JCOG1008: https://ascopubs.org/doi/full/10.1200/JCO.21.01293

Induction chemotherapy for NPC (Zhang et al.): https://www.nejm.org/doi/10.1056/NEJMoa1905287?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed